Evidence map›Paper›PMID 34697460›Full record

ArticleNature microbiology2021

Analysing the fitness cost of antibiotic resistance to identify targets for combination antimicrobials.

Aviram Rasouly, Yosef Shamovsky, Vitaly Epshtein, Kayan Tam, Nikita Vasilyev, Zhitai Hao, Giulio Quarta, Bibhusita Pani, Lingting Li, Carmen Vallin and 6 more

Abstract read
In one paragraph

Article in Nature microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Phenotypic and genetic stepwise changes inAntimicrobial agents and chemotherapy · 2025
    Article
  15. Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogens.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. In the shadow of antibiotics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Broad-spectrum tolerance to disinfectant-mediated bacterial killing due to mutation of the PheS aminoacyl tRNA synthetase.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Aviram Rasouly *Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Yosef Shamovsky *Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Vitaly EpshteinDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Kayan TamDepartment of Microbiology, New York University School of Medicine, New York, NY, USA.
Nikita VasilyevDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Zhitai HaoDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Giulio QuartaDepartment of Medicine, Division of Gastroenterology, NYU Langone Health, New York, NY, USA.
Bibhusita PaniDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Lingting LiDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Carmen VallinDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Ilya ShamovskyDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Shankarling KrishnamurthyDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Aaron ShtilermanDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Samantha VantineDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA.
Victor J TorresDepartment of Microbiology, New York University School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-7126-0489
Evgeny NudlerDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA. Evgeny.Nudler@nyumc.org.ORCID http://orcid.org/0000-0002-8811-3071

Funding

INFECTIOUS DISEASES &BASIC MICROBIOLOGICAL MECHANISMST32AI007180 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 1985 to 2022
$8.9M
Mechanistic Studies Of The Staphylococcus aureus LukAB CytotoxinR01AI099394 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Victor J. Torres · 2013 to 2026
$6.1M
Redefining the role of autophagy in bacterial diseaseR01AI121244 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 2017 to 2026
$5.6M
Contribution of LukED to Staphylococcus aureus pathobiologyR01AI105129 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI TORRES, VICTOR J. · 2014 to 2023
$4.9M
Transcription termination and gene regulation by Rho: Integrative analysisR01GM126891 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NUDLER, EVGENY A · 2018 to 2021
$2.3M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI099394NIAID NIH HHS R01 AI105129NIAID NIH HHS R01 AI121244NIAID NIH HHS T32 AI007180NIGMS NIH HHS R01 GM126891
6 · The paper itself

Abstract

Mutations in the rifampicin (Rif)-binding site of RNA polymerase (RNAP) confer antibiotic resistance and often have global effects on transcription that compromise fitness and stress tolerance of resistant mutants. We suggested that the non-essential genome, through its impact on the bacterial transcription cycle, may represent an untapped source of targets for combination antimicrobial therapies. Using transposon sequencing, we carried out a genome-wide analysis of fitness cost in a clinically common rpoB H526Y mutant. We find that genes whose products enable increased transcription elongation rates compound the fitness costs of resistance whereas genes whose products function in cell wall synthesis and division mitigate it. We validate our findings by showing that the cell wall synthesis and division defects of rpoB H526Y result from an increased transcription elongation rate that is further exacerbated by the activity of the uracil salvage pathway and unresponsiveness of the mutant RNAP to the alarmone ppGpp. We applied our findings to identify drugs that inhibit more readily rpoB H526Y and other Rif

Indexed as

Anti-Bacterial AgentsBacteriaBacterial ProteinsDNA-Directed RNA PolymerasesDrug Resistance, BacterialGenome, BacterialMutationRifampinTranscription, GeneticAnti-Bacterial AgentsBacterial ProteinsDNA-Directed RNA PolymerasesRifampin

Identifiers

PMID34697460
PMCPMC9389595

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.